MiR-885-3p is down-regulated in PBMCs from T1D patients and regulates the inflammatory response via targeting TLR4/NF-κB signaling.
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the progressive destruction of insulin-production pancreatic β cells. Recently, microRNAs (miRNAs) are emerging as important regulators in T1D. This study aimed to determine miR-885-3p expression in T1D patients and to examine the effects of miR-885-3p on the inflammatory response in human monocytes. Relevant gene expression levels were determined by qRT-PCR; western blot and enzyme-linked immunosorbent assays determined the respective protein levels; the interaction between miRNA and the downstream targets was evaluated using a luciferase reporter assay. MiR-885-3p is down-regulated and the levels of pro-inflammatory cytokines are increased in peripheral blood mononuclear cells (PBMCs) from T1D patients when compared to healthy controls. MiR-885-3p overexpression suppressed the mRNA expression and secreted protein levels of pro-inflammatory cytokines in THP-1. A luciferase reporter assay showed that miR-885-3p directly targeted the 3' untranslated region of Toll-like receptor 4 (TLR4), and miR-885-3p overexpression down-regulated TLR4 expression in THP-1 cells. The TLR4 mRNA expression level was increased in PBMCs isolated from T1D patients when compared to heathy controls. TLR4 overexpression increased the secretion of pro-inflammatory cytokines and enhanced the activity of NF-κB signaling, and attenuated the inhibitory effects of miR-885-3p overexpression on pro-inflammatory cytokines secretion and the activity of NF-κB signaling in THP-1 cells. This study identified the down-regulation of miR-885-3p and up-regulation of TLR4 in PBMCs isolated from T1D patients. Further mechanistic data demonstrated that miR-885-3p overexpression represses the production of pro-inflammatory cytokines via targeting TLR4/NF-κB signaling in the THP-1 cells.